Glen Allport (in 2009)

American healthcare should be cheap and getting cheaper, easy to access, effective yet rapidly improving, and with nearly endless options for treatment, pricing, and method of delivery. The cheaper-faster-better dynamic we enjoy in high-tech areas that are not blighted by government regulation and control could and would apply to the medical and pharmaceutical industries if only we let it.